MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 24, 2007; DOI: 10.1124/mol.107.039651


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.039651v1
73/1/252    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X.
Right arrow Articles by Jiang, L.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X.
Right arrow Articles by Jiang, L.-H.


Received for publication July 5, 2007.
Revised October 23, 2007.
Accepted for publication October 23, 2007.

Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper

Xing Liu 1, Annmarie Surprenant 2, Hong-Ju Mao 1, Sebastien Roger 2, Rong Xia 1, Helen Bradley 1, Lin-Hua Jiang 1*

1 University of Leeds 2 University of Sheffield

* Address correspondence to: E-mail: l.h.jiang{at}leeds.ac.uk

Abstract

P2X7 receptors are distinct from other ATP-gated P2X receptors in that they are potently inhibited by submicromolar concentrations of zinc and copper. The molecular basis for the strong functional inhibition by zinc and copper at this purinergic ionotropic receptor is controversial. We hypothesized that it involves a direct interaction of zinc and copper with residues in the ectodomain of the P2X7 receptor. There are 14 potential metal interacting residues conserved in the ectodomain of all mammalian P2X7 receptors, none of which are homologous to previously identified sites in other P2X receptors shown to be important for functional potentiation by zinc. We introduced alanine substitutions into each of these residues, expressed wild type and mutated receptors in HEK293 cells and recorded resulting ATP and BzATP-evoked membrane currents. Agonist concentration-response curves were similar for all the twelve functional mutant receptors. Alanine substitution at His62 or Asp197 strongly attenuated both zinc and copper inhibition, and the double mutant [H62A/D197A] mutant receptor was virtually insensitive to inhibition by zinc or copper. Thus, we conclude that zinc and copper inhibition is due to a direct interaction of these divalent cations with ectodomain residues of the P2X7 receptor, primarily involving combined interaction with His62 and Asp197 residues.


Key words: Purinergic, Purinergic, Structure determinations, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics